VANCOUVER, British Columbia – Life Sciences British Columbia (LSBC) announces the 31 companies to be featured at the 6th Annual Invest in BC presented by Lumira Ventures on November 3-4, 2021. This virtual conference features a wide range of life sciences of BC prepared for investors companies in the healthcare innovation ecosystem. The companies are looking for investors and strategic partners and have been selected after being awarded by a panel of expert investors. The launch sessions are held in front of an international audience of more than 250 investors, business leaders and registered government trade officials from more than 30 countries on six continents.
During the two-day online event, entrepreneurs will present their companies for funding from a wide range of stakeholders, including angel investors, venture capitalists, corporate risk leaders, and funding foundations. These sessions will focus on therapeutics, medical devices, medical technology, and digital health. Attendees will also have the opportunity to establish contacts through the virtual platform.
Invest in BC, presented by Lumira Ventures, is one of LSBC’s flagship events focused on investment and innovation. Throughout the year, LSBC programs and initiatives raise the profile of life sciences at home and abroad to foster investment and global partnership opportunities.
Life Sciences BC would like to thank all of our event sponsors (listed below) and appreciates the support of Lumira Ventures, our presenting sponsor and conference partner, adMare Bioinnovations.
“I am delighted to announce the 2021 BC-based life sciences companies selected to present at the sixth annual Life Sciences BC Invest in BC conference presented by Lumira Ventures. The life sciences sector in British Columbia encompasses a wide range of companies, from small and emerging to national and global, all in need of strong and strategic partnerships and investments. This conference will provide selected companies the opportunity to secure investment and new partnerships as they continue to advance their life science innovation products, solutions and services. ”
Wendy Hurlburt, President and CEO of Life Sciences BC
|4M BioTech||HTuO Biosciences||Sanitize|
|AltumView Systems Inc.||Mesentech Inc.||Sonic Incytes Medical Corp.|
|Axolotl Biosciences||Mesintel Therapeutics Inc.||Sustained Therapeutics Inc.|
|Azor Biotek INC||Microbiome insights||Total medical flow|
|Bold Therapeutics Inc.||Microbion Corporation||Vesalius Cardiovascular|
|Clairvoyant Therapeutics Inc.||NanoVation Therapeutics||Bioinnovation VoxCell|
|Claris Healthcare Inc.||NervGen Pharma Corp.||XCO Tech Inc.|
|Derm-Biome Pharmaceuticals Inc.||Oak Bay Biosciences, Inc.||YouCount Inc.|
|HeadCheck Health||Primary Peptides Inc.||Zennea Technologies Inc.|
|Herstasis Health Inc.||RepliCel Life Sciences|
|Tribune Medical Innovations|
|PRESENTING SPONSOR||CONFERENCE PARTNER|
|Lumira ventures||adMare bioinnovations|
|Session sponsors||Technology sponsor|
|AstraZeneca||Hey Wiggs LLP|
|entrepreneurship @ UBC|
|British Columbia Genomes||Network sponsor|
|Gowling WLG||Chinook Therapeutics|
|Novateur Ventures||Event supporters|
|Silicon Valley Bank||Berkley Canada|
|Canada Health Infoway|
|Johnson and Johnson Innovation|
For more details and to register for the event, visit: https://www.accelevents.com/e/investinbc
About Life Sciences BC
Life Sciences BC is a non-profit, non-governmental industry association that supports and represents the British Columbia life sciences community through leadership, investment and partnership facilitation, and advocacy of our industry and science. of World class.
Life sciences sectors, from biopharmaceuticals and medical technology, to digital health and medical devices, are integrated into our organization and in everything we do, ensuring that no life sciences sector work in isolation, and that all sectors come together in a comprehensive and complementary way. and coordinated fashion.
Throughout the year, Life Sciences BC carries out numerous programs and projects in support of these sectors. These include public policy initiatives, which facilitate links between the global industry and our local organizations, raise the profile of our industry internationally, and thus facilitate investment and global partnership opportunities, and help nurture the economic development in British Columbia through the life sciences industry.
Amanda Maxwell, Director of Marketing and Communications
Phone: 604-669-9909 Ext. 106
Email: [email protected]